VC-backed Personalis unveils IPO
Personalis Inc, a provider of advanced genomics solutions for cancer, has debuted its IPO after pricing its nearly 8 million shares at $17 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "PSNL." Morgan Stanley, BofA Merrill Lynch and Cowen are the lead underwriters. Personalis' pre-IPO backers included Lightspeed Venture Partners, Abingworth and Mohr Davidow Ventures.
20 June 2019•2 mins read
